Top Stocks to Consider for Long-Term Growth in 2025

Investors should consider top healthcare stocks for their portfolios. Pfizer, Eli Lilly, and Abbott Laboratories present growth potential and stability. These companies, detailed in a recent report, could deliver solid returns over the long term.

Date: 23-01-2025

AI Rating: 7

Investment Opportunities in Healthcare

This report highlights several healthcare companies that could have a significant impact on stock prices due to their strong growth potential and secure portfolios. Notably, it discusses:

Pfizer (PFE): Pfizer is shifting focus to its oncology business and aims to deliver at least eight oncology blockbusters by 2030. This strategic direction could indicate expected revenue growth from new product launches.
Eli Lilly (LLY): Eli Lilly's focus on weight loss drugs presents a substantial growth opportunity, particularly as the obesity drug market is expected to surpass $100 billion by the end of this decade. This strong demand coupled with ongoing manufacturing success suggests a positive trajectory for revenue growth.
Abbott Laboratories (ABT): Abbott is noted for its stability and consistent dividend payments, alongside achieving $6 billion in free cash flow. Its diversified business model provides a buffer against losses in any one area. This strong financial performance, especially in free cash flow, indicates further investment and growth potential.
Intuitive Surgical (ISRG): Intuitive's dominant position in robotic surgery and recurrent revenue stream offer strong growth prospects.
CRISPR Therapeutics (CRSP): Despite challenges, this company shows promise with potential product revenue from Casagevy and a rich pipeline of gene-editing candidates.

The report implies a positive outlook for the healthcare sector driven by innovative products and strong market demands. As a result, the companies mentioned are well-positioned for stock price growth over the long term.

Stocks: PFE LLY ABT ISRG CRSP